Lymphoma is a medical condition with active clinical research programs worldwide.

18 total trials for this combination

Showing top 10 of 18 trials

Trials

NCT ID	Title	Status	Phase
NCT00822120	S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma	COMPLETED	PHASE2
NCT02465060	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	ACTIVE_NOT_RECRUITING	—
NCT00005977	Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia	COMPLETED	PHASE3
NCT00003389	Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma	COMPLETED	PHASE3
NCT00004228	Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma	COMPLETED	PHASE3
NCT00002941	Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma	COMPLETED	PHASE2
NCT01415752	Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma	ACTIVE_NOT_RECRUITING	PHASE2
NCT02465060	Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)	ACTIVE_NOT_RECRUITING	—
NCT00006102	Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma	COMPLETED	PHASE2
NCT00897767	Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial	COMPLETED	—

Related Pages

All Lymphoma trials All trials in Morgantown, United States